Title: Elevated tHcy in Alzheimer Cause or result of disease
1(No Transcript)
2Smoking, folate and methylenetetrahydrofolate
reductase status as interactive determinants of
colorectal polyps and adenomas
3The C677T MTHFR polymorphismand folate
distribution
4Demographic and genetic characteristics of study
population
5Table 2. Clinicopathological diagnoses
Measure of growth given as median (range)
6Occurrence of colorectal polyps and adenomas
7Characteristics in terms of type, number and size
of colorectal polyps and adenomas
8Table 3. Homocysteine and vitamin status
according to gender and smoking
9Table 5. Predictors of plasma homocysteine by
multiple regression
10Odds ratios (95 CI) for the colonoscopic
outcomes for a one level increase in the
independent variable
11Odds ratios (95 CI) for the colonoscopic
outcomes for a one level increase in the
independent variable at low folate
12Odds ratios (95 CI) for the colonoscopic
outcomes for a one level increase in the
independent variable at high folate
13The C677T MTHFR polymorphism as risk factor of
significant lesion of colon-rectum at high and
low and high whole blood folate
14The interaction of smoking, folate status and the
C677T MTHFR polymorphism as risk factors of high
risk adenomas
15The interaction of smoking, folate status and the
C677T MTHFR polymorphism as risk factors of
adenomas 5mm of colon-rectum
16The interaction of smoking, folate status and the
C677T MTHFR polymorphism as risk factors of
hyperplastics polyps of colon-rectum
17Gene-environment interaction in the genetic
pathway to sporadic CRC
18Hypothetical model for the involvement of folate
and MTHFR status in the pathogenesis of
colorectal adenoma and cancer in smokers
19Conclusion
- Folate status and the C677T MTHFR SNP modulate
the procarcinogenic effect of smoking - High risk of large or villous or dysplastic
adenomas were observed in smokers with - low folate and the CT/TT genotypes
- high folate and the CC genotype
- Similar, but weaker relations were observed with
hyperplastic polyps
20(No Transcript)
21Relative risk (RR) for colon cancer according to
years since the start of use of multivitamins
containing folic acid in the Nurses Health Study
(1980-1994)
Modified fromGiovannucci et al (1998)Annals
Intern. Med. 129 517-524
22Odds ratio of colorectal cancer by MTHFR genotype
and plasma folate status among United States
physicians
Modified from Ma et al (1997) Cancer Res. 57
1098-1102
23Folate status and colorectal adenomas and cancer.
The evidence
- About 20 case-control studies and 3 prospective
studies including about 9000 patients - Most studies (12/16) based on dietary assessment
demonstrate a relation between folate status and
risk - Studies (5) based on measures of folate status in
blood provide discrepant results - Most intervention studies (5/7) demonstrate
reduction of parameters related to carcinogenesis
by folate - Modulation of colorectal carcinogenesis by folate
is supported by animal studies - Possible mechanisms
24Candidate mechanisms for folate-related
enhancement of carcinogenesis
- Induction of DNA hypomethylation
- Increased chromosomal fragility and/or diminished
DNA repair - Secondary choline deficiency
- Diminution in natural killer cell surveillance
- Misincorporation of uridylate for thymidylate in
DNA synthesis - Facilitation of tumorigenic virus metabolism
25Folate status has been associated with cancer in
- Lung
- Intervention trials
- Uterine cervix
- Dietary folate, blood folate measurement,
intervention trials - Esophagus, stromach and pancreas
- Ecological studies, dietary folate, blood folate,
intervention trials - Breast
- Dietary folate
- Colorectum
- Dietary folate, blood folate measurement,
intervention trials - S
26The effect of folic acid supplementation on
cervical dysplasia
Changes in cervical dysplasia in patients
receiving either placebo (n25) or folic acid
(n22). Cytological evaluation was made at 4
weeks intervals, and biopsy was at the fourth
visit (3 months of therapy) Butterworth et al
(1982) Am. J. Clin. Nutr. 35 73-82
27The T-allele of the C677T MTHFR polymorphism is
related to high plasma homocysteine and low
serum folate
28Serum and RBC folate in subjects with significant
colon lesion compared with controls